Pear Therapeutics Obtains First Medicaid Coverage For PDTs
Executive Summary
Massachusetts’ Medicaid program will cover reSET and reSET-O prescription digital therapeutics for the treatment of substance abuse disorder and opioid use disorder.
You may also be interested in...
Minute Insight: Are Things Going Pear-Shaped For Digital Therapeutics?
Pear Therapeutics is restructuring itself to lower costs following repeated disappointing performances.
Pear Adds Spanish Version Of Its Addiction Therapy PDTs
Availability of Spanish-language prescription digital therapeutics for the treatment of substance use disorder and opioid use disorder will address important health equity and health care disparities, according to Pear.
Pear CEO Sees Fulfilment And Reimbursement Challenges Ahead
Medtech Insight spoke to Pear Therapeutics CEO Corey McMann about the emerging digital therapeutics market and his company’s future now that it has the first PDT covered by Medicaid.